scholarly article | Q13442814 |
P356 | DOI | 10.1021/JA044883W |
P698 | PubMed publication ID | 15600307 |
P2093 | author name string | Hak Suk Chung | |
Daniel Kahne | |||
Kaori Sakurai | |||
P433 | issue | 50 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 16288-16289 | |
P577 | publication date | 2004-12-01 | |
P1433 | published in | Journal of the American Chemical Society | Q898902 |
P1476 | title | Use of a retroinverso p53 peptide as an inhibitor of MDM2 | |
P478 | volume | 126 |
Q33653633 | (D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha |
Q21284203 | A tale of two symmetrical tails: structural and functional characteristics of palindromes in proteins |
Q43198294 | An APP inhibitory domain containing the Flemish mutation residue modulates gamma-secretase activity for Abeta production |
Q34080613 | Beta-peptides with improved affinity for hDM2 and hDMX. |
Q34026523 | Design and synthesis of functionalized trisaccharides as p53-peptide mimics |
Q33424678 | Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions |
Q28534940 | Effect of sequence and stereochemistry reversal on p53 peptide mimicry |
Q37053063 | Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction |
Q86871587 | Global chain properties of an all l-α-eicosapeptide with a secondary α-helix and its all retro d-inverso-α-eicosapeptide estimated through the modeling of their CZE-determined electrophoretic mobilities |
Q34975505 | Integrating the intrinsic conformational preferences of noncoded α-amino acids modified at the peptide bond into the noncoded amino acids database |
Q27660480 | Limitations of Peptide Retro-inverso Isomerization in Molecular Mimicry |
Q36470847 | Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertension |
Q79733375 | Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide |
Q33802350 | Solution structure of a beta-peptide ligand for hDM2 |
Q58087195 | Targeted nanoswitchable inhibitors of protein-protein interactions involved in apoptosis |
Q35687836 | Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? |
Search more.